long half-life and large variability [Regulatives / Guidelines]

posted by Achievwin – US, 2020-08-12 15:22 (108 d 14:59 ago) – Posting: # 21864
Views: 587

Welcome to the home of funky and funny pharmacokinetics where "Garbage in Gospel out" is day of life.

1. allowing long washout periods have seen studies with 4 -5 months washout.
2. other choice we can imagine is Two stage adaptive study design and including ANCOA in place of ANOVA...

want to know what other experts think?

» In short:
  • pretty long half-life
  • huge total variablity (i.e. within + between variability)
  • total variability is expected to be explained to some degree by some covariates

Complete thread:

Activity
 Admin contact
21,216 posts in 4,427 threads, 1,481 registered users;
online 10 (0 registered, 10 guests [including 7 identified bots]).
Forum time: Sunday 05:21 CET (Europe/Vienna)

Half the harm that is done in this world
Is due to people who want to feel important.    T. S. Eliot

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5